• 1. A series of dinuclear cuprous iodide complexes chelated with 1,2-bis(diphenylphosphino)benzene derivatives: structural, photophysical and thermal properties
  Xiaoyue Li,Juanye Zhang,Feng Wei,Xiaochen Liu,Zhiwei Liu,Zuqiang Bian,Chunhui Huang CrystEngComm 2016 18 4388
• 2. Tuning liquid crystalline phase behaviour in columnar crown ethers by sulfur substituents
  Jochen Kirres,Katharina Schmitt,Iris Wurzbach,Frank Giesselmann,Sabine Ludwigs,Mark Ringenberg,Adrian Ruff,Angelika Baro,Sabine Laschat Org. Chem. Front. 2017 4 790
• 3. Towards high-performance heterogeneous palladium nanoparticle catalysts for sustainable liquid-phase reactions
  Beau Van Vaerenbergh,Jeroen Lauwaert,Pieter Vermeir,Joris W. Thybaut,Jeriffa De Clercq React. Chem. Eng. 2020 5 1556
• 4. The synthesis of biphenyl through C–H bond activation in benzene over a Pd catalyst supported on graphene oxide
  Deepika Sharma,Lyubov G. Bulusheva,Dmitri A. Bulushev,Neeraj Gupta New J. Chem. 2020 44 12178
• 5. Graphene based catalysts
  Cancan Huang,Chun Li,Gaoquan Shi Energy Environ. Sci. 2012 5 8848

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Application of 4-Bromo-1,2-difluorobenzene (CAS: 348-61-8) in Chemical Biology and Pharmaceutical Research

4-Bromo-1,2-difluorobenzene (CAS: 348-61-8) is a halogenated aromatic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and materials science applications. Recent studies have highlighted its role in the development of novel drug candidates, particularly in the areas of oncology and central nervous system (CNS) disorders.

One of the most notable advancements involving 4-Bromo-1,2-difluorobenzene is its use in the synthesis of fluorinated analogs of biologically active compounds. Fluorination is a common strategy in drug design to improve metabolic stability, bioavailability, and binding affinity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of 4-Bromo-1,2-difluorobenzene-derived compounds as potent inhibitors of protein kinases implicated in cancer progression. The study reported a significant reduction in tumor growth in preclinical models, underscoring the compound's potential in oncology therapeutics.

In addition to its pharmaceutical applications, 4-Bromo-1,2-difluorobenzene has been explored in materials science for the development of advanced polymers and liquid crystals. A recent publication in Advanced Materials detailed the synthesis of a novel class of fluorinated polymers using 4-Bromo-1,2-difluorobenzene as a building block. These polymers exhibited exceptional thermal stability and optical properties, making them suitable for use in high-performance electronic devices and optoelectronic applications.

The mechanistic insights into the reactivity of 4-Bromo-1,2-difluorobenzene have also been a focal point of recent research. A 2024 study in Organic Letters elucidated the compound's behavior under various catalytic conditions, providing a deeper understanding of its potential for selective functionalization. This research has paved the way for more efficient synthetic routes, reducing the environmental impact and cost associated with large-scale production.

Despite these advancements, challenges remain in the widespread adoption of 4-Bromo-1,2-difluorobenzene-based technologies. Issues such as scalability, regulatory compliance, and the need for further toxicological studies are areas that require ongoing investigation. However, the compound's unique properties and demonstrated efficacy in multiple applications position it as a promising candidate for future innovations in chemical biology and pharmaceutical research.

In conclusion, 4-Bromo-1,2-difluorobenzene (CAS: 348-61-8) continues to be a valuable tool in the arsenal of researchers and industry professionals. Its applications span from drug discovery to materials science, with recent studies highlighting its potential to address unmet medical and technological needs. As research progresses, it is anticipated that new and innovative uses for this compound will emerge, further solidifying its importance in the field.

• 1559-88-2(3-Bromo-1,2,4,5-tetrafluorobenzene)
• 64695-78-9(1,2-Dibromo-4,5-difluorobenzene)
• 1073-06-9(1-Bromo-3-fluorobenzene)
• 1435-51-4(1,3-Dibromo-5-fluorobenzene)
• 460-00-4(1-Bromo-4-fluorobenzene)
• 38573-88-5(1-Bromo-2,3-difluorobenzene)
• 1559-86-0(2,3,4,6-Tetrafluorobromobenzene)
• 1074-91-5(1-Bromo-2,3,4,5-tetrafluorobenzene)
• 327-52-6(1-Bromo-2,4,5-trifluorobenzene)
• 461-96-1(1-Bromo-3,5-difluorobenzene)